Sign inJoin waitlistJoin the waitlist

Jessica Bauman

Chief, Division of Head and Neck Medical Oncology · Temple University Hospital

Credentials: · · · · ·

History

Division of Head and Neck Medical Oncology · Temple University Hospital
Present
Temple University Hospital
Present

Harvard University
2011–2013
Dana-Farber Cancer Institute
2008–2011
Cornell Univ Joan and Sanford I Weill Med Coll
2004–2008

Research

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 1,060 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations

James Stevenson
14 papers
Billy Loo
13 papers
Dara Aisner
13 papers
Douglas Wood
13 papers
GR
Gregory Riely
13 papers
JL
Jules Lin
13 papers
Matthew Gubens
13 papers
Michael Lanuti
13 papers
Rudy Lackner
13 papers
TS
Theresa Shapiro
13 papers
Thomas Dilling
13 papers
Thomas Galloway
13 papers

Clinical trials

Impact of Ribociclib on Head and Neck Squamous Cell Cancer
Principal investigator · Terminated · Early phase 1
Fox Chase Cancer Center
2018–2019
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Principal investigator · Completed · Phase 2
Fox Chase Cancer Center
2011–2017
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Site PI · Recruiting · Phase 1, Phase 2
Nuvalent Inc.
2022–2028
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2026